{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T13:59:47Z","timestamp":1794923987166,"version":"4.9.1"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>Systemic sclerosis (SSc) is a multisystem autoimmune connective tissue disease characterized by early inflammation followed by excessive fibrosis in the skin and internal organs. Enhancing our comprehension of SSc pathogenesis is essential to develop effective therapeutic strategies. Animal models that mimic one or more aspects of SSc have been proven to be a valuable resource for investigating disease mechanisms. This review aims to provide an updated overview of the existing SSc animal models and the potentially relevant pathways to SSc pathogenesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>This review focuses on the most recently generated and investigated animal models, which delve into novel pathways beyond existing models or employ genetic technologies to gain a deeper understanding of SSc pathogenesis including activation of early type I interferon (IFN) signaling pathway, immune cell function and pulmonary artery hypertension (PAH).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>While no single animal model can fully replicate SSc, a combination of different models can offer valuable insights into the pathways involved in the onset and advancement of the SSc. These insights can prove animal models as a crutial preclinical tool for developing effective treatments for SSc.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/bor.0000000000000967","type":"journal-article","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T12:35:21Z","timestamp":1692707721000},"page":"364-370","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":17,"title":["Animal models in systemic sclerosis: an update"],"prefix":"10.1097","volume":"35","author":[{"given":"Xiongjie","family":"Bi","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, University of Texas Health Science Center at Houston, McGovern Medical School, Houston, Texas, USA"},{"name":"The first Affiliated Hospital, Guangxi University of Science and Technology, Liuzhou, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Mills","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston, McGovern Medical School, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghua","family":"Wu","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, University of Texas Health Science Center at Houston, McGovern Medical School, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,8,21]]},"reference":[{"key":"R1-20250526","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0889-857X(21)00892-9","article-title":"Systemic sclerosis","volume":"16","author":"Steen","year":"1990","journal-title":"Rheum Dis Clin N Am"},{"key":"R2-20250526","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.berh.2004.03.001","article-title":"Scleroderma--clinical and pathological advances","volume":"18","author":"Denton","year":"2004","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R3-20250526","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.berh.2004.03.003","article-title":"Skin manifestations of systemic autoimmune connective tissue disease: diagnostics and therapeutics","volume":"18","author":"Sontheimer","year":"2004","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R4-20250526","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.autrev.2010.09.016","article-title":"Fibrosis and immune dysregulation in systemic sclerosis","volume":"10","author":"Chizzolini","year":"2011","journal-title":"Autoimmun Rev"},{"key":"R5-20250526","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1046\/j.1523-1747.1999.00528.x","article-title":"Animal model of sclerotic skin. I: Local injections of bleomycin induce sclerotic skin mimicking scleroderma","volume":"112","author":"Yamamoto","year":"1999","journal-title":"J Invest Dermatol"},{"key":"R6-20250526","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11926-008-0030-9","article-title":"In perspective: murine models of scleroderma","volume":"10","author":"Wu","year":"2008","journal-title":"Curr Rheumatol Rep"},{"key":"R7-20250526","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/00001622-199511000-00015","article-title":"Interferons: laboratory to clinic investigations","volume":"7","author":"Platanias","year":"1995","journal-title":"Curr Opin Oncol"},{"key":"R8-20250526","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev.biochem.67.1.227","article-title":"How cells respond to interferons","volume":"67","author":"Stark","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"R9-20250526","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/art.39658","article-title":"Identification of optimal mouse models of systemic sclerosis by interspecies comparative genomics","volume":"68","author":"Sargent","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"R10-20250526","article-title":"Endothelial response to type I interferon contributes to vasculopathy and fibrosis and predicts disease progression of systemic sclerosis","author":"Yin","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"R11-20250526","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/337270a0","article-title":"Induction of endogenous IFN-alpha and IFN-beta genes by a regulatory transcription factor, IRF-1","volume":"337","author":"Fujita","year":"1989","journal-title":"Nature"},{"key":"R12-20250526","doi-asserted-by":"crossref","first-page":"6660","DOI":"10.1093\/emboj\/17.22.6660","article-title":"Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7","volume":"17","author":"Marie","year":"1998","journal-title":"EMBO J"},{"key":"R13-20250526","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0014-5793(98)00210-5","article-title":"Involvement of the IRF family transcription factor IRF-3 in virus-induced activation of the IFN-beta gene","volume":"425","author":"Sato","year":"1998","journal-title":"FEBS Lett"},{"key":"R14-20250526","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.immuni.2007.06.009","article-title":"The feedback phase of type I interferon induction in dendritic cells requires interferon regulatory factor 8","volume":"27","author":"Tailor","year":"2007","journal-title":"Immunity"},{"key":"R15-20250526","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nature03308","article-title":"Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors","volume":"434","author":"Takaoka","year":"2005","journal-title":"Nature"},{"key":"R16-20250526","doi-asserted-by":"crossref","first-page":"15136","DOI":"10.1073\/pnas.1520997112","article-title":"Multifaceted contribution of the TLR4-activated IRF5 transcription factor in systemic sclerosis","volume":"112","author":"Saigusa","year":"2015","journal-title":"Proc NAtl Acad Sci USA"},{"key":"R17-20250526","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1146\/annurev.immunol.19.1.623","article-title":"IRF family of transcription factors as regulators of host defense","volume":"19","author":"Taniguchi","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"R18-20250526","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0014-5793(98)01514-2","article-title":"Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7","volume":"441","author":"Sato","year":"1998","journal-title":"FEBS Lett"},{"key":"R19-20250526","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/annrheumdis-2019-215208","article-title":"Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis","volume":"78","author":"Wu","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"R20-20250526","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nature03464","article-title":"IRF-7 is the master regulator of type-I interferon-dependent immune responses","volume":"434","author":"Honda","year":"2005","journal-title":"Nature"},{"key":"R21-20250526","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.4049\/jimmunol.170.6.3059","article-title":"The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets","volume":"170","author":"Hemmi","year":"2003","journal-title":"J Immunol"},{"key":"R22-20250526","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1182\/blood-2003-08-2674","article-title":"Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9","volume":"103","author":"Krug","year":"2004","journal-title":"Blood"},{"key":"R23-20250526","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s13238-012-2104-8","article-title":"Regulation of TLR7\/9 signaling in plasmacytoid dendritic cells","volume":"4","author":"Bao","year":"2013","journal-title":"Protein Cell"},{"key":"R24-20250526","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.jid.2021.02.015","article-title":"Downregulated IRF8 in monocytes and macrophages of patients with systemic sclerosis may aggravate the fibrotic phenotype","volume":"141","author":"Ototake","year":"2021","journal-title":"J Invest Dermatol"},{"key":"R25-20250526","doi-asserted-by":"crossref","first-page":"5855","DOI":"10.4049\/jimmunol.0803705","article-title":"Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse","volume":"182","author":"Servettaz","year":"2009","journal-title":"J Immunol"},{"key":"R26-20250526","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.3389\/fimmu.2019.01861","article-title":"The fibrosis and immunological features of hypochlorous acid induced mouse model of systemic sclerosis","volume":"10","author":"Meng","year":"2019","journal-title":"Front Immunol"},{"key":"R27-20250526","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00296-023-05328-z","article-title":"Structural and functional characteristics of the pulmonary hemomicrocirculatory bed in induced systemic sclerosis: an experimental study","volume":"43","author":"Doskaliuk","year":"2023","journal-title":"Rheumatol Int"},{"key":"R28-20250526","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.3390\/microorganisms8081220","article-title":"Surviving reactive chlorine stress: responses of gram-negative bacteria to hypochlorous acid","volume":"8","author":"da Cruz Nizer","year":"2020","journal-title":"Microorganisms"},{"key":"R29-20250526","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0738-081X(94)90295-X","article-title":"Animal models of systemic sclerosis","volume":"12","author":"Jimenez","year":"1994","journal-title":"Clin Dermatol"},{"key":"R30-20250526","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.trsl.2015.06.018","article-title":"Interferon regulatory factor 5 in human autoimmunity and murine models of autoimmune disease","volume":"167","author":"Eames","year":"2016","journal-title":"Transl Res"},{"key":"R31-20250526","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.3389\/fimmu.2018.02434","article-title":"Pharmacological inhibition of toll-like receptor-4 signaling by TAK242 prevents and induces regression of experimental organ fibrosis","volume":"9","author":"Bhattacharyya","year":"2018","journal-title":"Front Immunol"},{"key":"R32-20250526","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.tice.2018.11.006","article-title":"Antifibrotic effect of black tea (Camellia sinensis) extract in experimental pulmonary fibrosis","volume":"56","author":"Chakraborty","year":"2019","journal-title":"Tissue Cell"},{"key":"R33-20250526","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jdermsci.2019.08.005","article-title":"The significance of tumor cells-derived MFG-E8 in tumor growth of angiosarcoma","volume":"96","author":"Fujiwara","year":"2019","journal-title":"J Dermatol Sci"},{"key":"R34-20250526","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1006\/cimm.1996.0017","article-title":"Correlation between the concentration of serum antitopoisomerase I autoantibodies and histological and biochemical alterations in the skin of tight skin mice","volume":"167","author":"Hatakeyama","year":"1996","journal-title":"Cell Immunol"},{"key":"R35-20250526","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1172\/JCI116675","article-title":"Immunochemical and molecular characterization of anti-RNA polymerase I autoantibodies produced by tight skin mouse","volume":"92","author":"Shibata","year":"1993","journal-title":"J Clin Invest"},{"key":"R36-20250526","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1172\/JCI0215078","article-title":"CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse","volume":"109","author":"Saito","year":"2002","journal-title":"J Clin Invest"},{"key":"R37-20250526","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/art.1780381212","article-title":"The tight skin 2 mouse. An animal model of scleroderma displaying cutaneous fibrosis and mononuclear cell infiltration","volume":"38","author":"Christner","year":"1995","journal-title":"Arthritis Rheum"},{"key":"R38-20250526","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/jid.2014.455","article-title":"The Tsk2\/+ mouse fibrotic phenotype is due to a gain-of-function mutation in the PIIINP segment of the Col3a1 gene","volume":"135","author":"Long","year":"2015","journal-title":"J Invest Dermatol"},{"key":"R39-20250526","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.4049\/jimmunol.175.4.2418","article-title":"Demonstration of autoimmunity in the tight skin-2 mouse: a model for scleroderma","volume":"175","author":"Gentiletti","year":"2005","journal-title":"J Immunol"},{"key":"R40-20250526","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/art.20160","article-title":"A modified model of graft-versus-host-induced systemic sclerosis (scleroderma) exhibits all major aspects of the human disease","volume":"50","author":"Ruzek","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R41-20250526","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/2211-5463.12268","article-title":"A modified graft-versus-host-induced model for systemic sclerosis, with pulmonary fibrosis in Rag2-deficient mice","volume":"7","author":"Yang","year":"2017","journal-title":"FEBS Open Bio"},{"key":"R42-20250526","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.vph.2012.12.001","article-title":"The Fra-2 transgenic mouse model of systemic sclerosis","volume":"58","author":"Maurer","year":"2013","journal-title":"Vascul Pharmacol"},{"key":"R43-20250526","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1136\/annrheumdis-2016-210823","article-title":"Nintedanib inhibits macrophage activation and ameliorates vascular and fibrotic manifestations in the Fra2 mouse model of systemic sclerosis","volume":"76","author":"Huang","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R44-20250526","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","article-title":"Nintedanib for systemic sclerosis-associated interstitial lung disease","volume":"380","author":"Distler","year":"2019","journal-title":"N Engl J Med"},{"key":"R45-20250526","doi-asserted-by":"crossref","first-page":"2102347","DOI":"10.1183\/13993003.02347-2021","article-title":"Pirfenidone exacerbates Th2-driven vasculopathy in a mouse model of systemic sclerosis-associated interstitial lung disease","volume":"60","author":"Birnhuber","year":"2022","journal-title":"Eur Respir J"},{"key":"R46-20250526","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.3899\/jrheum.151322","article-title":"An open-label, phase II study of the safety and tolerability of pirfenidone in patients with scleroderma-associated interstitial lung disease: the LOTUSS trial","volume":"43","author":"Khanna","year":"2016","journal-title":"J Rheumatol"},{"key":"R47-20250526","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00296-020-04565-w","article-title":"Efficacy and safety of pirfenidone in systemic sclerosis-related interstitial lung disease\u2014a randomised controlled trial","volume":"40","author":"Acharya","year":"2020","journal-title":"Rheumatol Int"},{"key":"R48-20250526","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1002\/art.41309","article-title":"Tumor necrosis factor induces obliterative pulmonary vascular disease in a novel model of connective tissue disease-associated pulmonary arterial hypertension","volume":"72","author":"Bell","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"R49-20250526","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1101\/gad.5.6.908","article-title":"Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1","volume":"5","author":"Ben-David","year":"1991","journal-title":"Genes Dev"},{"key":"R50-20250526","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.1038\/ncomms6797","article-title":"Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis","volume":"5","author":"Noda","year":"2014","journal-title":"Nat Commun"},{"key":"R51-20250526","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1128\/MCB.01278-08","article-title":"Transcription factor Fli1 regulates collagen fibrillogenesis in mouse skin","volume":"29","author":"Asano","year":"2009","journal-title":"Mol Cell Biol"},{"key":"R52-20250526","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1084\/jem.20160247","article-title":"Epithelial Fli1 deficiency drives systemic autoimmunity and fibrosis: possible roles in scleroderma","volume":"214","author":"Takahashi","year":"2017","journal-title":"J Exp Med"},{"key":"R53-20250526","article-title":"Molecular mechanisms behind the role of plasmacytoid dendritic cells in systemic sclerosis","volume":"12","author":"Silva","year":"2023","journal-title":"Biology (Basel)"},{"key":"R54-20250526","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1136\/annrheumdis-2020-218439","article-title":"Targeting human plasmacytoid dendritic cells through BDCA2 prevents skin inflammation and fibrosis in a novel xenotransplant mouse model of scleroderma","volume":"80","author":"Ross","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"R55-20250526","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1084\/jem.194.12.1823","article-title":"BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha\/beta induction","volume":"194","author":"Dzionek","year":"2001","journal-title":"J Exp Med"},{"key":"R56-20250526","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1002\/art.30539","article-title":"Immunization with DNA topoisomerase I and Freund's complete adjuvant induces skin and lung fibrosis and autoimmunity via interleukin-6 signaling","volume":"63","author":"Yoshizaki","year":"2011","journal-title":"Arthritis Rheum"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000967","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T17:21:08Z","timestamp":1748280068000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,21]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000967","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,21]]}}}